Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,780.00
Bid: 1,779.50
Ask: 1,780.00
Change: 6.50 (0.37%)
Spread: 0.50 (0.028%)
Open: 1,780.00
High: 1,781.00
Low: 1,771.50
Prev. Close: 1,773.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EXECUTIVE CHANGES: AIB adds two to board; Lamprell taps ex-Aramco exec

Tue, 14th Sep 2021 15:02

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Tuesday and not separately reported by Alliance News:

----------

AIB Group PLC - Dublin-based bank - Hires Tanya Horgan and Jan Sijbrand as independent non-executive directors, starting immediately. Horgan, an accountant, was most recently chief risk officer for gambling operator Flutter Entertainment PLC. Sijbrand currently is a member of the Supervisory Board of PricewaterhouseCoopers Nederland. As an executive, he worked at lenders ABN Amro Holding NV, Rabobank Nederland and NIBC Bank NV. He also was chair for Supervision at De Nederlandsche Bank NV, the Dutch central bank.

----------

Lamprell PLC - Sharjah, UAE-based engineer for energy industry - Hires Motassim Al Maashouq as independent non-executive director, starting Tuesday. Al Maashouq retired from Saudi Arabian Oil Co in June of last year. At Aramco, he held senior roles including vice president of New Business Development, VP of Corporate Planning, and group treasurer.

----------

AEX Gold Inc - exploration licences in Greenland, including Nalunaq gold mine - Hires James Gilbertson as vice president for Exploration. Gilbertson, a geologist, was managing director of SRK Exploration and has been a consultant to AEX for the past six years.

----------

Bonhill Group PLC - London-based business-to-business media - Anne Donoghue will resign as non-executive director from September 30, due to a new full-time commitment. Bonhill says a search for a new non-executive director is underway.

----------

Caribbean Investment Holdings Ltd - holding company for banking and corporate services businesses based in Belize - Hires Stewart Howard as non-executive director, starting immediately. Howard is chief executive officer of Waterloo Investment Holdings Ltd and managing director of British Caribbean Bank Ltd.

----------

Bivictrix Therapeutics PLC - Macclesfield, England-based drug development company specialising in cancer treatments - Hires Oliver Schon as vice president of Product Development and Chemistry Manufacturing & Controls. Schon is a cancer researcher who previously worked at GlaxoSmithKline PLC and Agenus Inc.

----------

Trinity Exploration & Production PLC - oil assets in Trinidad and Tobago - Hires Derek Hudson as independent non-executive director, starting immediately. Hudson is a geologist with 30-years experience in the oil and gas industry, including at BG Group and subsequently at BG's acquirer Royal Dutch Shell PLC. He currently is non-executive chair of Scotiabank Trinidad & Tobago Ltd.

----------

Tertiary Minerals PLC - mining projects in Zambia, Europe and the US state of Nevada - Hires Patrick Cullen as managing director, starting immediately. Cullen was CEO at AIM-listed Arkle Resources PLC.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.